Moreover, it was also suggested that DEHP activates Jun-N-terminal kinase (JNK), promoting the apoptosis of hepatic cells and the inhibition of insulin sensitivity, which may lead to metabolic disorders [89,90]. The gene discussed is MAPK8; the disease is metabolic disease.